Please help with this asap.I post the questions below and the two different articles we get this info from. In below I give the link and also add the news/articles picture.Recently, Bangladesh University of Engineering and Technology (BUET), mHealth Lab developed a low cost ventilator to help during the ongoing COVID-19 pandemic.Read the following published news " https://mhealth.buet.ac.bd/oxyjet/ ". Then ans the questions. Question :(a) Identify possible intangible assets or intellectual properties that may have resulted from the above invention.(b) What Intellectual Property( protection(s) should the Lab seek for? (c) Why? Explain for each protection type. A team of engineers from Bangladesh University of Engineering and Technology (BUET) has developed a low-cost oxygen supply instrument called OxyJet, an innovation which may offer lifeline to people severely affectedby the Covid-19 in countries like Bangladesh.According to the engineers involved, OxyJet can present effective treatment solution to Covid-19 patients bysupplying high-flow oxygen with positive pressure. The coronavirus attacks people's lungs and causes breathingproblems.OxyJet is a C-PAP ventilator, which uses the pressure of the medical oxygen source to generate a high-flow of airand oxygen mixture using the jet-mixing principle.It can deliver up to 60 litres of oxygen per minute, said the team leader of theপিন সেটproject undertaken by the BUET's Department of Biomedical Engineering.To create high-flow oxygen, it requires a C-PAP (Continuous Positive Air-wayPressure) ventilator, a conventional one which could cost up to Tk 100,000.করলেই নগদ-এThe OxyJet C-PAP would not require such cost but would be more efficientsolution to this problem, Dr. Taufiq Hasan, an assistant professor and the teamleader of the project told this author.পিন সেটFirstly, according to project document, the system is completely mechanical anddoesn't require electricity. This provides the machine an edge over traditionalC-PAPS which would require constant electricity and cannot be used in remoteareas or in an ambulance. Secondly, the device costs about Tk 2,000 only (full system, with masks and cylindercosts more) which is a fraction of the traditional market price."Conventional C-PAPS use a vented mask which disperses virus particles in the air through aerosolization. We usea tightly fitted non-vented C-PAP mask with a viral filter to reduce such contamination," said the team leader.He explained that all traditional C-PAPS do not include an oxygen port in the inlet and thus cannot provide anoxygen concentration (FiO2) up to 100 per cent. "OxyJet C-PAP is designed for treating hypoxemic patients inmind and can provide up to 100 per cent FiO2. Besides, Oxyjet is very easy to use for doctors as its user interfaceconsists of a flow-meter knob, that can be rotated to increase or decrease the oxygen flow."The team believes the project is promising as it would be able to provide low-cost, energy efficient and valuablehigh-pressure oxygen for patients, even beyond the pandemic. Amidst the ongoingcountrywide strain on thesupply of medical oxygen,researchers at Buet'sDepartment of BiomedicalEngineering havedeveloped a portableventilator that gives ushope for the near future.The device, named OxyJetCPAP, is a non-invasive onethat can be used withoutelectricity by simply beingconnected to an oxygencylinder or medical oxygensupply. The researchershave developed it keeping in mind the plight of severe Covid-19 patients with low oxygen levels. This ventilator willalso be cost-effective, as it can be produced at Tk 25,000 now., and will require an even lower cost once it goes intocommercial production. It has already been field-tested and approved for clinical trials and is currently in its third-phase trial.The second wave of the pandemic has brought to light many deficiencies in our healthcare system, one of the majorones being the lack of resources. Be it ICU beds or an even and consistent supply of oxygen for every patient, peoplehave had to suffer immensely for these deficiencies. Though not a long-lasting solution, the OxyJet CPAP would be agreat device to have during emergencies for critical Covid-19 patients as it "can provide up to 60 litres/min of 100percent oxygen" before admission into the ICU. The device would also eliminate the potential risks of using invasiveventilators and it is also much cheaper than the usual high-flow nasal oxygen (HFNO) support devices. Plus, it canbe used by any physician with ease after only an hour of training, unlike a HFNO cannula for which there are notenough expert operators in the country.lchange Filter

Question

Please help with this asap.I post the questions below and the two different articles we get this info from. In below I give the link and also add the news/articles picture.Recently, Bangladesh University of Engineering and Technology (BUET), mHealth Lab developed a low cost ventilator to help during the ongoing COVID-19 pandemic.Read the following published news &#34; https://mhealth.buet.ac.bd/oxyjet/ &#34;. Then ans the questions. Question :(a) Identify possible intangible assets or intellectual properties that may have resulted from the above invention.(b) What Intellectual Property( protection(s) should the Lab seek for? (c) Why? Explain for each protection type. A team of engineers from Bangladesh University of Engineering and Technology (BUET) has developed a low-cost oxygen supply instrument called OxyJet, an innovation which may offer lifeline to people severely affectedby the Covid-19 in countries like Bangladesh.According to the engineers involved, OxyJet can present effective treatment solution to Covid-19 patients bysupplying high-flow oxygen with positive pressure. The coronavirus attacks people's lungs and causes breathingproblems.OxyJet is a C-PAP ventilator, which uses the pressure of the medical oxygen source to generate a high-flow of airand oxygen mixture using the jet-mixing principle.It can deliver up to 60 litres of oxygen per minute, said the team leader of theপিন সেটproject undertaken by the BUET's Department of Biomedical Engineering.To create high-flow oxygen, it requires a C-PAP (Continuous Positive Air-wayPressure) ventilator, a conventional one which could cost up to Tk 100,000.করলেই নগদ-এThe OxyJet C-PAP would not require such cost but would be more efficientsolution to this problem, Dr. Taufiq Hasan, an assistant professor and the teamleader of the project told this author.পিন সেটFirstly, according to project document, the system is completely mechanical anddoesn't require electricity. This provides the machine an edge over traditionalC-PAPS which would require constant electricity and cannot be used in remoteareas or in an ambulance. Secondly, the device costs about Tk 2,000 only (full system, with masks and cylindercosts more) which is a fraction of the traditional market price.&#34;Conventional C-PAPS use a vented mask which disperses virus particles in the air through aerosolization. We usea tightly fitted non-vented C-PAP mask with a viral filter to reduce such contamination,&#34; said the team leader.He explained that all traditional C-PAPS do not include an oxygen port in the inlet and thus cannot provide anoxygen concentration (FiO2) up to 100 per cent. &#34;OxyJet C-PAP is designed for treating hypoxemic patients inmind and can provide up to 100 per cent FiO2. Besides, Oxyjet is very easy to use for doctors as its user interfaceconsists of a flow-meter knob, that can be rotated to increase or decrease the oxygen flow.&#34;The team believes the project is promising as it would be able to provide low-cost, energy efficient and valuablehigh-pressure oxygen for patients, even beyond the pandemic. Amidst the ongoingcountrywide strain on thesupply of medical oxygen,researchers at Buet'sDepartment of BiomedicalEngineering havedeveloped a portableventilator that gives ushope for the near future.The device, named OxyJetCPAP, is a non-invasive onethat can be used withoutelectricity by simply beingconnected to an oxygencylinder or medical oxygensupply. The researchershave developed it keeping in mind the plight of severe Covid-19 patients with low oxygen levels. This ventilator willalso be cost-effective, as it can be produced at Tk 25,000 now., and will require an even lower cost once it goes intocommercial production. It has already been field-tested and approved for clinical trials and is currently in its third-phase trial.The second wave of the pandemic has brought to light many deficiencies in our healthcare system, one of the majorones being the lack of resources. Be it ICU beds or an even and consistent supply of oxygen for every patient, peoplehave had to suffer immensely for these deficiencies. Though not a long-lasting solution, the OxyJet CPAP would be agreat device to have during emergencies for critical Covid-19 patients as it &#34;can provide up to 60 litres/min of 100percent oxygen&#34; before admission into the ICU. The device would also eliminate the potential risks of using invasiveventilators and it is also much cheaper than the usual high-flow nasal oxygen (HFNO) support devices. Plus, it canbe used by any physician with ease after only an hour of training, unlike a HFNO cannula for which there are notenough expert operators in the country.lchange Filter

Accepted Answer

Intellectual property: Intellectual property is a general clear-cut depiction of the arrangement…

Question : (a) Identify possible intangible assets or intellectual properties that may have resulted from the above invention. (b) What Intellectual Property( protection(s) should the Lab seek for? (c) Why? Explain for each protection type